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he current work by Tiruvoipati and colleagues1 measures substantive defi
ciencies in the reporting of randomized trials in the surgical literature.
Among other things, the authors of that report indicate that lack of awareness
f the CONSORT guidelines2 contributes to the deficiencies they observed. 
annot know for sure whether the problems in the surgical literature are worse than
n other contexts, but we think they are because of the general underapplication of
igorous experimental design methods for clinical questions in surgery.3
The Tiruvoipati study1 is a review of problems relatively near the end o
videntiary pipeline. However, I believe it is helpful to reflect on the whole culture
nd process of therapeutic inference in surgery to understand how the literature
ight be improved and, in turn, how the literature might improve the science. This
eans examining investigators’ attitudes and beliefs, the mindset of peer reviewers,
he role of surgical journals, and the demands of readers.
With regard to attitudes and beliefs, surgeons have regularly been taught some
hings that dissuade them from relying on experimental methods. These include a
reat deal of respect for opinion and experience, the anticipation of large treatment
ffects, the reliability of incremental improvements in a surgical procedure, the
ifficulty and/or non-necessity of randomization, an underappreciation of selection
nd observer bias, and confidence in favorable risk/benefit ratios in properly selected
atients. Such beliefs support the adequacy of relatively informal methods for
valuating treatments and are descendants of historical authoritarianism in medi-
ine. Other contexts, like therapeutic development of drugs, have appropriately and
uccessfully replaced the authoritarian perspective with an experimental one be-
ause the beliefs listed above are not routinely true and because of our frequent need
o detect modest-sized but valuable treatment effects. Drug regulation has been
nstrumental in effecting this change.
Drug developers and other nonsurgeons can provide worthwhile alternative
iews to some of the attitudes and beliefs of surgeons regarding rigorous clinical
rial methodology. An example is the value, validity, feasibility, and frequent
ecessity of randomization as a device to remove bias and increase reliability.
reatment masking also deserves more than a customary dismissal. Also, many
urgical treatment effects, when present, are modest in size. Such mitigating, rather
han curative, effect sizes require large rigorous trials to provide convincing
vidence.
Much of what is taught to young investigators is carried over to those who peer
eview manuscripts, where scientific culture reinforces itself. It is not enough to
now that trial reporting guidelines are relevant to a particular study and make them,
n part, the currency of a review. What is more important is to see beyond reporting
eaknesses and assess the true quality of the trial. Even more useful is the ability
o know what research design is appropriate and possible and gauge the strength of
vidence on that basis. Unavoidably, therapeutic questions in surgery confound 3
ffects: (1) efficacy of the procedure, (2) prognosis through patient selection, and (3)
ractitioner skill and supportive care. Strength of evidence from a surgical study
epends largely on the ability of the research design to separate those effects,
specially the first and second. It can be intimidating as a reviewer to imagine
ejecting a superficially well-done study because of critical design flaws.
Journal editors play a crucial role in quality improvement that goes beyond the
rooming of manuscripts. Culling is their most powerful tool, and it has to be
pplied aggressively if a journal is to improve itself. Multiple journals that improve
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TShemselves will begin to elevate the scientific discipline.
his gives the editorial process considerable leverage and
mportance. As a repository of the scientific culture that
peaks from both past and present, it is vital to improve
ournals energetically. Journal editors lack direct influence
n many matters (eg, determining which questions are ad-
ressed by research studies), but we should not underesti-
ate the breadth of power they wield.
The problem of improving clinical trials in surgery
omes full circle when considering how the demands of
eaders affects the science. Readers’ expectations depend on
nowledge, attitudes, and beliefs acquired in training and
hrough experience, and they exercise those demands in two
ays. First, the effect of a published clinical trial probably
epends as much on the receptivity of the audience as on the
uality of the science. The “word on the street” or lack of it
epends on receptivity, as does the willingness of readers to
48 The Journal of Thoracic and Cardiovascular Surgery ● Auguncorporate published findings into both their clinical and
esearch practices. Second, readers translate their demands
nto concrete decisions as peer reviewers. Thus the disci-
line is not necessarily hard wired for progress but instead
elies on the influence of teachers, of which journal editors
re one example. In this way the article by Tiruvoipati and
olleagues1 points to a direction for improvement.
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